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Background: Early diagnosis and improved treatment outcomes have increased breast cancer survival rates that, in turn, have led
to increased numbers of women undergoing follow-up after completion of primary treatment. The current workload growth is
unsustainable for breast cancer specialists who also provide care for women newly diagnosed or with a recurrence. Appropriate
and acceptable follow-up care is important; yet, currently we know little about patient preferences. The aim of this study was to
explore the preferences of Australian breast cancer survivors for alternative modes of delivery of follow-up services.
Methods: A self-administered questionnaire (online or paper) was developed. The questionnaire contained a discrete choice
experiment (DCE) designed to explore patient preferences with respect to provider, location, frequency and method of delivery of
routine follow-up care in years 3, 4 and 5 after diagnosis, as well as the perceived value of ‘drop-in’ clinics providing additional
support. Participants were recruited throughout Australia over a 6-month period from May to October 2012. Preference scores and
choice probabilities were used to rank the top 10 most preferred follow-up scenarios for respondents.
Results: A total of 836 women participated in the study, of whom 722 (86.4%) completed the DCE. In the absence of specialist
follow-up, the 10 most valued surveillance scenarios all included a Breast Physician as the provider of follow-up care. The most
preferred scenario is a face-to-face local breast cancer follow-up clinic held every 6 months and led by a Breast Physician, where
additional clinics focused on the side effects of treatment are also provided.
Conclusion: Beyond the first 2 years from diagnosis, in the absence of a specialist led follow-up, women prefer to have their
routine breast cancer follow-up by a Breast Physician (or a Breast Cancer Nurse) in a dedicated local breast cancer clinic, rather
than with their local General Practitioner. Drop-in clinics for the management of treatment related side effects and to provide
advice to both develop and maintain good health are also highly valued by breast cancer survivors.
Breast cancer is the most common incident form of malignancy
in Australia accounting for 28% of cancer diagnoses in
2008 (Australian Institute of Health and Welfare & Cancer
Australia, 2012). It is a well-characterised disease with clear
guidelines available through Cancer Australia for follow-up of
women with early breast cancer (National Breast and Ovarian
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Cancer Centre, 2010). Cancer Australia has defined the aims and
objectives of follow-up: to detect and treat local recurrence, to deal
with adverse effects of treatment, to provide psychological support,
to screen for a new primary breast cancer, review and update
family history, observe outcomes of therapy and review treatment
including the potential for new therapies (National Breast
and Ovarian Cancer Centre, 2010). In addition, Cancer Australia
identifies that there is a lack of clarity about the ‘optimal
duration and frequency of follow-up’, and it is apparent that
this is a contentious area (Dixon and Montgomery, 2008;
Cameron, 2008).
Clinical cancer services around Australia are facing a rapid
expansion in workload through a combination of three factors:
(a) unprecedented ageing of the population leading to numbers in
the cancer-prone age-groups growing more quickly than the
incidence rates of cancer are falling; (b) higher proportion of cases
of both incident and recurrent cancer being deemed treatable, with
treatment regimes becoming progressively more complex; and
(c) improving outcomes of treatment, expanding the pool of
survivors (Australian Institute of Health and Welfare & Cancer
Australia, 2012). There are economic and workforce imperatives to
changing models of care and reconfiguring service provision within
the public health sector. Relevant research suggests that nurses may
be better at identifying psychological concerns and side-effects of
drug treatment than clinicians (Dixon and Montgomery, 2008),
and shared cared models of breast cancer follow-up between
Cancer specialists and General Practitioners have recently been the
focus of a demonstration project within Australia by Cancer
Australia (Cancer Australia, 2013).
Patient preferences can also inform clinical decision-making
and improve satisfaction and adherence to health programmes
(Lancasar and Louviere, 2008). Discrete choice experiments (DCE)
have become a commonly used technique in health economics
(Ryan et al, 2006). The technique is an attribute-based measure of
benefit, based on the assumption that interventions (e.g., breast
cancer follow-up services) can be described by a number of salient
or key attributes (characteristics) and that an individual’s valuation
of the intervention depends upon the levels of these attributes
(De Bekker-Grob et al, 2012). Important attributes may be
identified from literature reviews, expert clinical opinion, patient
focus groups or individual patient interviews. Patients are given
hypothetical scenarios comprising different levels of attributes and
asked to choose between two or more alternatives. Patients’
stated preferences reflect their perceived benefit, where benefit
is defined in terms of the economic concept of ‘utility’ or value
(Ryan et al, 2006).
Given limited resources, if we are considering designing new
follow-up services that are both appropriate and acceptable to
women, we need to understand which attributes of the service
women value most. The aim of this study was to determine the
preferences of breast cancer survivors for possible alternative
modes of delivery of follow-up services in years 3, 4 and 5 after
diagnosis.
MATERIALS AND METHODS
Producing scenarios. Salient attributes and levels for inclusion
within the DCE were established from a literature review. We
searched in PubMed from inception through to December 31,
2011, limiting to original papers, literature reviews or systematic
reviews published in English. Key search terms were text words
‘breast cancer’, ‘follow*’, ‘surveillance’, ‘monitoring’, ‘survivor*’,
and MESH terms ‘patient satisfaction’ and ‘patient preference*’.
Papers that focused on either the experiences of women under-
going breast cancer follow-up or on women’s preferences for
alternative modes of delivery of follow-up services were sought.
In reviewing the identified papers, greater weight was given to
recent Australian publications.
A key set of papers included a recently published body of
qualitative research on breast cancer follow-up in Australia.
Australian women reported a high level of satisfaction with their
current specialist-based care and an initial reluctance to consider
models of care that would involve them moving away from the
cancer specialist (Brennan et al, 2011a). There was also a perceived
need for additional training of GPs or Breast Cancer Nurses if they
were to have an increased role in follow-up care (Brennan et al,
2011b). Patients highlighted psychosocial needs and menopausal
symptoms as areas of the follow-up consultation that needed
improving (Brennan et al, 2011b).
While recognising advantages to GP follow-up, there was a
stronger level of support for shared care between the GP and a
specialist, rather than a complete transfer to GP led care (Brennan
et al, 2011a). We explicitly excluded the shared care option as the
objective of the study was to identify alternatives to specialist
follow-up, and previous research has shown that respondents tend
to prefer what they know best or have experienced (Salkeld et al,
2000; Kimman et al, 2010a).
Four attributes relating to service organisation were identified:
type of provider, location, frequency and method of delivery of
routine follow-up care. A fifth attribute was created from ‘gaps’
described in the literature relating to existing service provision,
with the intent to evaluate the perceived benefit of offering ‘drop-
in’ clinics to provide additional support to women living with
breast cancer. On the basis of the literature and expert
consultation, three levels for each of the five attributes were
developed to examine characteristics of interest to the Australian
health care context:
1. Clinician
(a) Breast Physician: usually General Practitioners who have
undergone specialised training in breast medicine (http://
breastphysicians.org/index.php?option=com_content&
view=article&id=1&ltemid=2).
(b) General Practitioner: local doctor providing whole person
health care to individuals and families in the community,
(http://www.racgp.org.au/becomingagp/what-is-a-gp/
what-is-general-practice/).
(c) Breast Cancer Nurse: registered nurse with additional
training and certification in breast cancer care (National
Breast Cancer Centre, 2005).
2. Frequency – every 6, 9 or 12 months.
3. Location – hospital clinic, general practice, local breast cancer
follow-up clinic.
4. Method – face-to-face, telephone, alternate between face-to-face
and telephone.
5. Drop-in clinics – treatment side effects, psychosocial support,
secondary prevention.
The 5 3 design resulted in 254 (35) possible scenarios.
We used a fractional factorial design and the techniques developed
by Street and Burgess to reduce this to a more pragmatic 18 binary
choice sets, which were 100% efficient for the estimation of main
effects (Burgess, 2006). This design was then divided into three
blocks or versions, each containing a total of six choice sets
for presentation to participants. The detailed definition of the
chosen attributes and attribute levels for the DCE are presented
in Table 1.
The questionnaire started with a short introduction on the
background to the research study and an explanation of what
the questionnaire would involve (including a practice example).
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The first section of the questionnaire contained the discrete choice
experiment. In the preamble, participants were given a hypothe-
tical context (Figure 1), followed by a comprehensive description of
each of the attributes and levels. Women were then asked to
complete six questions. Each question contained a pair-wise choice,
and participants were asked to choose the option they most
preferred for their routine follow-up appointments in years 3, 4
and 5 following diagnosis of breast cancer (Figure 2). The second
section consisted of background information regarding demo-
graphics, family history, features related to breast cancer diagnosis,
treatment and follow-up, and self-assessed level of anxiety
regarding cancer and other health concerns (Gotay and Pagano,
2007) (Supplementary Appendix A). The questionnaire was
designed principally for online administration. However, a paper
version was made available upon request for women who expressed
a preference for a paper version and/or who did not have easy
access to the internet.
A small pilot study (n¼ 10) was administered by one author
(TB) in a follow-up breast clinic at a major public hospital in
Adelaide. The main objectives of the pilot study were to establish
face validity and identify any problems in understanding the
requirements of the questionnaire or individual questions. Feed-
back from the pilot study resulted in some minor changes in
question wording to improve clarity.
Recruitment. Patients with a personal history of breast cancer,
who had completed their primary treatment (surgery, radiotherapy
and chemotherapy), were eligible for the study.
Women were recruited from a variety of settings including
Breast Surgical Oncology clinics (SA only) in both the public and
private health sector, local and national print media, and patient
support and advocacy groups including Cancer Voices SA, Cancer
Council Australia, Breast Cancer Network of Australia, National
Breast Cancer Foundation and Register 4, over a 6-month period
from May to October 2012.
Patients recruited through their treating clinician were provided
with a study envelope at the end of their consultation if they met
the inclusion criteria. The patient, if willing to participate,
was asked to complete the questionnaire at home and return the
questionnaire within the stamped addressed envelope provided, or
alternatively access the survey online using the URL provided in
the Letter of Invitation within the study envelope.
Patient support and advocacy groups were asked to disseminate
a short description of the study to their members through their
usual communication channels. Patients were also recruited
through print media (a local newspaper, magazine for senior
citizens and a state-based journal of the Australian Medical
Association). Women who chose to participate could either
complete the survey online or contact the research team requesting
a study envelope to be posted to them.
Block randomisation occurred at the online survey site, and by
ensuring that each clinician received an equal number of all three
versions of the survey to provide to their patients.
Ethics approval. Approval was obtained from the Human
Research Ethics Committees of the University of Adelaide, and
Table 1. Attributes and levels
Attributes Levels Description
Clinician Breast Physician Most are General Practitioners who have undergone additional training in breast assessment, planning and
coordinating breast cancer treatment and counsellinga
General Practitionerþ þ Your local doctor who provides person centred, continuing, comprehensive and coordinated whole person
health care to individuals and families in their communities.a This is your own local doctor whom you normally
see when you get sick (e.g., coughs and colds, blood pressure, diabetes, infections etc)
Breast Cancer Nurse A registered nurse who has completed extra study (a Graduate Diploma or higher at University) in the specialty
of cancer nursing or its equivalenta
Frequency Every 6 months Follow-up visit scheduled every 6 months
Every 9 months Follow-up visit scheduled every 9 months
Every 12 monthsþ þ Follow-up visit scheduled every 12 months
Location Hospital clinic A breast cancer follow-up clinic at the hospital where you had your treatment, but you would no longer be seen
by the cancer specialist/s who provided your surgery, chemotherapy or radiotherapy
General practiceþ þ Your local general practice
Local breast cancer follow-up
clinic
A breast cancer follow-up clinic in your local area
Method Face-to-face A visit to a clinician where you would have a clinical breast examination and discussion about your well-being
and issues related to your breast cancer care
Telephoneþ þ At a scheduled time, a clinician telephones you and you have a discussion about your well-being and issues
related to your breast cancer care
Alternate between face-to-
face & telephone
Your first appointment is a clinic visit, your second appointment is by telephone, your third appointment is a
clinic visit and so on
It is important to note that if your care was provided by telephone but it becomes clear that you needed a face-to-face appointment,
this would be arranged within 1 week
Drop-in
clinics
Treatment side effects clinic For management of lymphedema, menopausal symptoms, sexual dysfunction etc that relate to your surgery,
chemotherapy or radiotherapy for breast cancer
Psychosocial support
clinicþ þ
For identification, referral and management of depression, anxiety and issues relating to self-image,
relationships and return to work
Secondary prevention clinic For advice about diet, alcohol and exercise, to both develop and maintain good health and reduce the risk of
breast cancer returning
Notes: þ þ Reference group in modelling.
aAdapted from sources outlined in Methods section.
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each of the three public and three private Adelaide hospitals
participating in the study.
Socio-economic status. Socio-economic status was classified
using the Socio-Economic Indexes for Areas, 2006 (SEIFA 2011
had not been released at the time of writing), from the Australian
Bureau of Statistics (http://www.abs.gov.au/AUSSTATS/abs@.nsf/
allprimarymainfeatures/356A4186CCDDC4D1CA257B3B001AC2
2C?opendocument). The Postal Area (POA) Index of Relative
Socio-Economic Advantage and Disadvantage (IRSAD) was
applied to derive national deciles from individual postcodes, with
decile 1 indicating the most disadvantaged and decile 10 the most
advantaged areas.
Data analysis. The DCE data were analysed within a random
utility maximisation framework (McFadden, 1973). The empirical
model to be estimated is specified as: Uitj ¼ x0itjbiþeitj, where Uitj is
the utility individual i derives from choosing alternative j in choice
scenario t, xitj is a vector of observed attributes of alternative j, bi is
a vector of individual specific coefficients reflecting the desirability
of the attributes and eitj is a random error term. In order to
investigate the potential for preference heterogeneity, the mixed
logit model, also known as the random parameter logit model, was
utilised (McFadden and Train, 2000; Hole, 2007; Eberth et al,
2009). Within the mixed logit model, the bi is expressed as b þ Zi,
where b constitutes the vector of average preferences of the
population for each attribute and Zi is the individual’s specific
preference components. In this study, it is assumed that all
coefficients of attribute levels are random with normal distribution
and are freely correlated. The utility function for the DCE was of
the following form:
Uitj ¼ b1þZ1ið ÞPhysicianiþ b2þZ2ið ÞNurseiþ b3þZ3ið ÞSix Monthsi
þ b4þZ4ið ÞNine Monthsiþ b5þZ5ið ÞFollow up Clinici
þ b6þZ6ið ÞHospital Cliniciþ b7þZ7ið ÞFace 2 facei
þ b8þZ8ið ÞAlternateiþ b9þZ9ið ÞSideffectsi
þ b10þZ10ið ÞPreventioniþeitj
where Physician and Nurse are dummy variables for Breast
Physician and Breast Cancer Nurse in the clinician attribute,
SixMonths and NineMonths are dummy variables indicating every
6 or 9 months in the follow-up frequency attribute, FollowupClinic
and HospitalClinic are dummy variables representing local breast
cancer follow-up clinic and hospital clinic in the location attribute;
Face2face and Alternate are dummy variables indicating face-to-
face and alternate between face-to-face and telephone for the
Programme A Programme B
Breast Physician General Practitioner
Every 6 months Every 12 months
Face-to-face Alternate between face-to-face and telephone
Hospital clinic 
Secondary prevention clinics available
Programme A
Programme B
* Scenarios varied over 18 pair-wise choices
Local breast cancer follow-up clinic
Psychosocial support clinics available
Figure 2. Example of a DCE question*.
For the purpose of this study, please imagine the following:
Your breast cancer care is provided by a cancer specialist at the hospital for the first 2 years after
your diagnosis and you are then discharged to follow-up care with a different clinician in a different
location. This medical practitioner would be responsible for your routine follow-up appointments in
years 3, 4 and 5; however, if a serious problem arose, you would be referred immediately back to the
cancer specialist who provided your initial treatment (please note that your follow-up would still
continue beyond 5 years, but for the purpose of this study we would like you to focus on years 3, 4
and 5). You would be expected to attend your routine follow-up appointments at this new location.
This new location also runs weekly ‘‘drop-in’’ clinics for further advice and support about living with
breast cancer. These ‘‘drop-in’’ clinics are in addition to your routine follow-up appointments,
require no booking, and you can use them as little or as often as you wish.
You will be asked to answer six questions about hypothetical breast cancer follow-up programs. Each
question contains a pair of options for you to choose between. The features of the follow-up
programs will differ in the following five ways:   
1. Which clinician would provide your care
2. How often your appointments would be
3. Where your follow-up appointment would occur
4. Type of routine follow-up appointment
5. Type of additional drop-in clinics offered
Figure 1. Preamble to DCE.
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method attribute, Sideffects and Prevention are dummy variables
for treatment side effects clinic and secondary prevention clinic for
the Drop-in clinics attribute. All attributes were dummy coded,
with one level for each attribute coded as the referent (refer to
Tables 1 and 2 for referent levels).
From the fitted model, a statistically significant parameter
estimate for an attribute level indicates its importance in
influencing the preferences of respondents. A positive (negative)
sign indicates that this attribute level is preferred (not preferred) to
the base level of the attribute. Internal validity (i.e., the extent to
which results are consistent with a priori expectations) was tested
by examining the sign and significance of parameter estimates.
We expected all attributes to have a significant influence on
preferences for follow-up. On the basis of our literature review and
expert opinion, the a priori assumptions were that more frequent
face-to-face visits with a General Practitioner (GP)/specialist GP
(Breast Physician) in a local community setting close to home,
which provided additional psychosocial support clinics, would be
the most preferred follow-up options for years 3–5 in our
hypothetical scenarios.
The main outputs from the mixed logit model are estimates of
the proportions of respondents who prefer each attribute level,
compared with the reference level for each attribute. For example,
for the attribute ‘health-care provider’, the proportion of the
population with a preference for Breast Physician compared with a
General Practitioner can be estimated. Following Kimman et al,
(2010a), a series of interaction terms between the attribute levels
and respondents’ characteristics (reflecting socio-economic status,
education and clinical characteristics including the number of
years since initial diagnosis, age at diagnosis and the type of breast
cancer diagnosed) were included into the utility function to further
explore possible observable sources of preference heterogeneity.
Preference scores (Vj—also called ‘indirect utility scores’; Ryan
et al, 2006) were generated as the sum of the model coefficients for
every combination of attribute levels. The probability that each






k¼1 exp Vkð Þ
where j ¼ 1, y, J. In this paper, only the 10 most highly ranked
scenarios are considered.
RESULTS
Characteristics of respondents. A total of 836 women accessed
the survey, of whom 722 (86.4%) completed the DCE and were
included in the analysis. Of the participants, 75.6% were born in
Australia and 98.2% were non-indigenous. The largest number of
responses were from the most densely populated states (New South
Wales 26.7%, South Australia 26.5%, Victoria 19.8% and Queens-
land 17.2%), but all states and territories were represented.
At diagnosis, the majority of women had early invasive breast
cancer (74.1%) and were between 40 and 60 years of age (67.8%).
The largest group of respondents were 2–5 years post diagnosis
(40.7%), followed by women 5–10 years post diagnosis (26.6%).
Most study participants (83.5%) saw a cancer specialist (breast
surgeon, medical oncologist, radiation oncologist and specialist
registrar in training) most frequently for their breast cancer follow-
up. Complete characteristics of the respondents are presented in
Supplementary Appendix A.
Discrete choice experiment results. The mixed logit estimates for
the total sample are reported in Table 2. As hypothesised a priori,
all attributes were found to have a significant influence on
preferences for follow-up. The results indicate that women
demonstrated strongest positive preferences for a Breast Physician
Table 2. Mixed logit estimates for total sample
Mean coefficient s.d.
Attributes Levels Reference level for each attribute Coefficient s.e. Coefficient s.e.
Clinician Breast Physician Compared with having General Practitioner to provide your care 2.692** 0.331 1.911** 0.279
Breast Cancer Nurse 1.167** 0.207 2.191** 0.315
Frequency Every 6 months Compared with the frequency of appointments is every 12 months 0.375* 0.166 1.615** 0.298
Every 9 months 0.178 0.149 1.049** 0.284
Location Local breast cancer
follow-up clinic
Compared with the follow-up appointment location is at local
general practice
1.118** 0.172 0.805* 0.349
Hospital clinic 0.016 0.169 1.232** 0.341
Method Face-to-face Compared with the routine follow-up appointment by phone 2.711** 0.311 1.855** 0.334
Alternate face-to-face
and telephone





Compared with the psychosocial support clinic 0.898** 0.196 1.240** 0.377
Secondary prevention
clinics







Abbreviations: AIC¼ akaike information criterion; N¼number of Halton draws: 500. Random parameters correlated.
**Po0.01,
*Po0.05.
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(followed by a Breast Cancer Nurse), 6-monthly visits, local breast
cancer clinic, face-to-face attendance (followed by alternate face-
to-face and telephone) and drop-in clinics for treatment side effects
(followed by secondary prevention; all Po0.05). The parameter
estimates relating to face-to-face follow-up and the Breast
Physician were in the expected direction, providing evidence of
internal validity. The statistically significant standard deviation (s.d.).
of all random coefficients (Po0.05) also confirmed the existence of
preference heterogeneity. As all coefficients of attribute levels are
assumed to be normally distributed, the mixed logit estimates relating
to the mean coefficient and s.d. for each attribute level were applied
to calculate the distribution of preference heterogeneity. For example,
the coefficient (s.d.) of Breast Physician is 2.692 (1.911), indicating
that 92% of the respondents exhibited a preference for the breast
cancer follow-up service to be provided by a Breast Physician.
Similarly, the results indicate that 70% of respondents would prefer
to see a Breast Cancer Nurse over a General Practitioner and 59% of
respondents would prefer to have appointments every 6 months
over every 12 months.
The extent to which preference heterogeneity was related to
observable characteristics was explored by including the interaction
terms between respondents’ characteristics and attribute levels.
No interaction terms were found to be statistically significant
suggesting that preference heterogeneity was largely un-
observable and was not systematically related to respondents’
characteristics.
Predicting choice probabilities for different breast cancer
follow-up scenarios. To illustrate respondent preferences for the
factors in combination, Table 3 presents the 10 most valued
surveillance strategy scenarios, all of which included a Breast
Physician as the provider of follow-up care. The most preferred
scenario is a face-to-face local breast cancer follow-up clinic held
every 6 months and led by a Breast Physician, where additional
clinics focused on the side effects of treatment are also provided.
The data indicate that women would prefer to reduce the
frequency of follow-up from 6 to 9 months rather than alter the
location or method of delivery, but they would accept alternating
methods of delivery, and follow-up to be based at a hospital based
clinic, to a decrease in follow-up frequency to 12 monthly. The
rankings also show that women would be prepared to accept
alternating methods of delivery (face-to-face and telephone-based
visits) before switching the location of the clinic to a hospital
setting.
DISCUSSION
Our results demonstrate clear preferences of Australian breast
cancer survivors for delivery of their follow-up care in the absence
of specialist follow-up in years 3, 4 and 5. Breast Physicians were
the most preferred provider, followed by Breast Cancer Nurses and
then General Practitioners. Breast Physicians bring a specialist level
of knowledge to survivorship care with many of the benefits of a
GP approach (Brennan and Jefford, 2009). The observed
preference for Breast Cancer Nurses to local GPs suggests that
specialised training in breast medicine is valued by respondents.
Additional reasons for this order of preferences could be explored
by qualitative research, but was beyond the scope of this study. A
follow-up service located in the community had broad appeal to
women, and, while face-to-face visits were preferred, women would
consider alternating face-to-face visits with telephone contact if
this meant that the frequency of contact with the follow-up service
was not reduced.
To our knowledge, this is only the second discrete choice
experiment investigating patient preferences for breast cancer
follow-up and the first in an Australian context. Kimman et al
(2010a) used DCE methodology to assess patient preference for the
first year of breast cancer follow-up in the Netherlands, described
by attributes of attendance at an educational group programme,
frequency of visits, waiting time, contact mode and type of health-
care provider, for 331 women. The authors demonstrated that
‘overall patient satisfaction would be similar if patients were
followed up by a medical specialist alternating with a Breast Cancer
Nurse compared with follow-up by a medical specialist only’.
Kimman et al (2010a) also found preference heterogeneity for most
attributes, ‘indicating that one strategy does not fit all’.
It is important to note that our study differs from Kimman’s
study in a number of key areas. First, we elicited the views and
preferences of a large sample of Australian women previously
treated for breast cancer, with no fixed time since completion of
treatment. Second, the attributes and levels included in our study
were also notably different from those selected by Kimman et al
(2010a). The attributes and levels were carefully chosen to reflect
the Australian health system and the current policy context
whereby alternative modes of delivery of follow-up services are
being considered to reduce the burden upon cancer specialist.
Hence, the cancer specialist was removed from the scenario.
Deliberately removing the cancer specialist from the follow-up
Table 3. Preference scores & predicted probabilities within the top 10 breast cancer follow-up scenarios
Clinician Frequency Location Method Drop-in clinics
Preference
score Probability Rank
Breast Physician Every 6 months Local breast cancer follow-up clinic Face-to-face Treatment side effects clinics 7.794 0.192 1
Breast Physician Every 9 months Local breast cancer follow-up clinic Face-to-face Treatment side effects clinics 7.597 0.158 2
Breast Physician Every 6 months Local breast cancer follow-up clinic Face-to-face Secondary prevention clinics 7.300 0.117 3
Breast Physician Every 6 months Local breast cancer follow-up clinic Alternate face-to-
face and telephone
Treatment side effects clinics 7.228 0.109 4
Breast Physician Every 9 months Local breast cancer follow-up clinic Face-to-face Secondary prevention clinics 7.103 0.096 5
Breast Physician Every 9 months Local breast cancer follow-up clinic Alternate face-to-
face & telephone
Treatment side effects clinics 7.031 0.090 6
Breast Physician Every 6 months Local breast cancer follow-up clinic Alternate face-to-
face & telephone
Secondary prevention clinics 6.734 0.067 7
Breast Physician Every 6 months Hospital clinic Face-to-face Treatment side effects clinics 6.692 0.064 8
Breast Physician Every 9 months Local breast cancer follow-up clinic Alternate face-to-
face & telephone
Secondary prevention clinics 6.537 0.055 9
Breast Physician Every 9 months Hospital clinic Face-to-face Treatment side effects clinics 6.495 0.052 10
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scenarios was also designed to help reduce the effect of people
tending to prefer what they know best (the so called ‘status quo
bias’ (Salkeld et al, 2000), which had been reported in the Kimman
et al (2010a) study. By including a Breast Physician, a Breast
Cancer Nurse and a General Practitioner, we were able to examine
how women’s preferences might be influenced by specialised
knowledge of breast medicine (specialist GP vs general GP) and
clinician craft group (specialist GP vs specialist nurse). We also
chose not to offer a shared care option, as we sought to identify the
single key clinician women would prefer to oversee their follow-up
care. A community based site for follow-up was offered as an
alternative to hospital based care, where the opportunity to attend
drop-in clinics to address areas of unmet need was also provided.
By offering a hypothetical local breast cancer follow-up clinic,
we could assess whether a publicly funded community location for
follow-up would be acceptable to breast cancer survivors.
Brennan et al (2011b) identified a perceived need for additional
training of GPs or Breast Cancer Nurses if they were to have an
increased role in follow-up care. Our study has confirmed that if
patients cannot see a breast cancer specialist, the specialised
knowledge of breast medicine is of more importance to women
than the clinician craft group. This is in contrast to a Canadian
randomised controlled trial of long-term follow-up for early-stage
breast cancer, which demonstrated that follow-up by the patient’s
own family physician was a safe and acceptable alternative to
traditional hospital-based specialist-led follow-up (Grunfeld et al,
2006). Mitigating factors include a 55% study recruitment rate,
which suggest that almost half of the patients ‘will be unwilling to
have follow-up care transferred to their family physician’ (p 853),
and the authors also state that the study did not specifically
measure the ‘special psychosocial and supportive care concerns’ of
breast cancer patients. Our study demonstrates a high level of
patient support for breast cancer nurses as providers of follow-up
care in the absence of follow-up provided by a medically qualified
cancer specialist. This finding is in line with the results of a
Swedish randomised multicentre study that compared a nurse-
based follow-up system with clinic visits on demand to routine
follow-up by a specialist in oncology or surgery (Koinberg et al,
2004). The study demonstrated that the two strategies were similar
in terms of patients’ well-being, satisfaction and access to medical
services, and there was no difference between the groups
concerning time to recurrence or death.
Brennan et al (2011b) also highlighted psychosocial needs and
menopausal symptoms as areas of the follow-up consultation that
needed improving . Our study showed that patients valued drop-in
clinics for treatment-related side effects (which includes meno-
pausal symptoms) most strongly, over secondary prevention clinics
and psychosocial support clinics. This suggests that sequelae of
breast cancer treatment are currently not being adequately
addressed during follow-up. Our results concur with three recent
observational studies in Australia, examining the prevalence and
severity of morbidity in breast cancer survivors. One study revealed
that many breast cancer survivors report long-term breast-related
morbidity (functional status, cosmetic status and breast-specific
pain) that was unaffected by time since surgery, and that the extent
of loco-regional therapies were significant predictors of poorer
health-related quality of life outcomes (Tian et al, 2013). Another
study followed participants for over 6 years, allowing for the
estimation of the prevalence of a predefined range of adverse
treatment effects over time (Schmitz et al, 2013). At 6 years after
diagnosis, more than 60% of women were experiencing one or
more adverse treatment effects, but the proportion of women
experiencing three or more side effects decreased throughout
follow-up. The results are most applicable to women who had
extensive axillary surgery (as recruitment occurred before sentinel
lymph node biopsy becoming widespread in Australia); however,
the study may still underestimate the true prevalence of adverse
treatment effects, as it did not capture chemotherapy and
endocrine therapy-related sequelae. Another smaller study found
that women with higher levels of symptom burden following
treatment for early breast cancer reported significantly higher
interference with personal goals and objectives, and psychological
distress, than women with a lower symptom burden (Stefanic
et al, 2013).
Our findings also indicate that although face-to-face visits with a
clinician were preferred, women would consider alternating face-
to-face visits with telephone contact if this meant that the
frequency of contact with the follow-up service was not reduced.
This supports previous research that demonstrated cautious
support for alternative modes of delivery of care. For example, a
US study suggested that, for women to accept an alternative model
of care, they need to understand what it entails, and to be reassured
about the safety of the new option. In that study, patients rated a
virtual telephone/internet visit as having less impact on cancer-
related worrying and cancer survival, than face-to-face visits with
clinicians (Mayer et al, 2012). The authors suggested that a lack of
detail in the definition of a virtual visit within the questionnaire
may have led to misunderstanding about this option and
contributed to the negative response. In contrast, a randomised
equivalence trial in the United Kingdom, comparing traditional
hospital follow-up and telephone follow-up by breast cancer
nurses, after treatment for breast cancer with low-to-moderate risk
of recurrence, demonstrated that ‘patients in the telephone arm of
the study had higher levels of satisfaction but did not have higher
levels of anxiety as a result of foregoing clinical examinations and
face-to-face appointments’ (Beaver et al, 2009). In addition, there
was no difference between the two groups in time to detection of
recurrent disease. These findings are similar to a Netherlands
study, which addressed patient satisfaction with nurse-led
telephone follow-up in the first year after curative treatment for
breast cancer (Kimman et al, 2010b). The researchers concluded
that regular phone contact with a breast care nurse, and a one year
mammography combined with a hospital visit, was of equal value
to traditional hospital follow-up visits, in terms of access of care,
technical competence, interpersonal aspects and general
satisfaction.
While breast physician-led follow-up in local breast cancer
clinics were the top nine most preferred scenarios in our study,
there are some foreseeable barriers to implementing breast
physician-led clinics in the community in Australia. For example,
some have noted doubt about ‘whether the current and future
availability of breast physicians is adequate to meet the need of the
increasing numbers of breast cancer survivors in Australia’ (Bell
et al, 2013). A recent pilot study in Western Australia hypothesised
that patients treated for breast cancer would benefit from targeted
therapy delivered by general practitioners based on recommenda-
tions of a multidisciplinary team (MDT) based in primary care
(Jiwa et al, 2013). This small study demonstrated that, while MDT
is feasible in primary care, and most patients who then consult a
GP will benefit, the logistics of organising the reviews (meeting
venue, breast care nurse as care coordinator, access to an electronic
health record), and the cost implications of providing care in the
community ‘need careful consideration’. Current funding systems
may have an impact here. Under current Australian funding
arrangements, patients treated in the community (including GP
visits) may be subject to payment of a ‘gap fee’ above the
Commonwealth Government Medicare rebates, whereas patients
who are treated in State health funded hospitals are not charged a
fee for further care at public hospitals (Jiwa et al, 2013).
The advent of widespread Internet access and growing
experience with video-conferencing may provide a more attractive
option for women in rural and remote areas of Australia, who
could be seen by their local General Practitioner and have regular
case conferences with multiple care providers simultaneously from
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their own home or local general practice clinic. Further research
could apply DCE methodology to investigate the preferences of
women who live in rural and remote areas, for this new mode of
technology.
The strengths of our study include the large sample size
(n¼ 722) and national sample frame. The attributes and levels in
the study were informed by international literature and con-
temporary qualitative research on the experiences, needs and
preferences of breast cancer survivors in Australia (Jiwa et al, 2010;
Brennan et al, 2011a, b; Jiwa et al, 2011; Lawler et al, 2011). The
limitations of this study include lack of recruitment by breast
clinicians in states and territories other than South Australia, that
women had to be literate in English to participate, and we were
unsuccessful in recruiting breast cancer survivors of Aboriginal or
Torres Strait Islander descent (ATSI comprised o2% of the
respondents). The results may not be representative of women
from non-English speaking backgrounds or indigenous commu-
nities, but addressing these limitations was beyond the scope of the
current study. Nonetheless, our study sample is large and diverse,
and is likely to be generalisable to English-speaking women in
Australia.
Identification of training requirements, and careful workforce
planning and modelling would be required to ensure that ‘specialist
GP’ led breast cancer follow-up clinics avoid exacerbating
current GP workforce shortages (Jiwa et al, 2007). It would
also be important to explore barriers to specialists discharging
their patients to follow-up by a different clinician and how
this may be influenced by characteristics of the individual
professional, the patient (e.g. age, co-morbid anxiety or
depression, social support, urban vs rural/remote etc), the
primary breast cancer (e.g. low, medium or high risk of
recurrence) or other factors.
CONCLUSION
In the absence of cancer specialists, in years 3, 4 and 5 following
diagnosis, Australian women would prefer to have their routine
breast cancer follow-up provided by a Breast Physician (or a Breast
Cancer Nurse) in a dedicated local breast cancer clinic, rather than
with their local General Practitioner. Drop-in clinics for the
management of treatment-related side effects and to provide advice
to both develop and maintain good health are also highly valued by
breast cancer survivors.
In the light of financial pressures that reduce the feasibility of
almost all follow-up services being provided by breast cancer
specialists, this study provides important insights into those
attributes of a breast cancer follow-up service that women value
most. Our results can help inform the design of alternative
service pathways that are acceptable to patients, for which
further assessments of costs and patient outcomes can be
undertaken.
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